
Insilico partners with Eli Lilly on AI drug discovery
Drug discovery company Insilico Medicine has entered a research collaboration with pharmaceutical giant Eli Lilly to advance AI-driven drug discovery. Insilico will use its validated Pharma.AI platform to generate, design, and optimise candidate compounds against targets defined under the agreement. The company is eligible to… Read More















